Xenon Pharmaceuticals Inc. – Filings and Transcripts

NASDAQ: XENE
Share price (6/3/26): $53.46
Market cap (6/3/26): $5.168 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

Machado Patrick

Gover Justin D.

Garofalo Elizabeth A.

News Filter

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Reports Q1 2026 Financial Results and Provides Business Update

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

RE: Xenon Pharmaceuticals Inc

Material Definitive Agreement, Other Events, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Confidential treatment order